학술논문

Dose escalation and expansion phase I studies with the tumour-targeting antibody-tumour necrosis factor fusion protein L19TNF plus doxorubicin in patients with advanced tumours, including sarcomas
Document Type
Article
Source
In: European Journal of Cancer. (European Journal of Cancer, June 2021, 150:143-154)
Subject
Language
English
ISSN
18790852
09598049